Insulin Delivery Devices Market share forecast to witness considerable growth from 2017 to 2024 - PowerPoint PPT Presentation

About This Presentation

Insulin Delivery Devices Market share forecast to witness considerable growth from 2017 to 2024


Insulin pens accounted for highest market share in 2016, owing to its benefits such as its user-friendly design, high adoption rate, and increasing acceptance amongst consumers. Rising focus of companies on product innovation should yield the high industry share. For example, Novo Nordisk launched a new device called NovoPen Echo in the U.S. It was the first device of its kind, with a half-unit dosage feature and memory function. – PowerPoint PPT presentation

Number of Views:28


Transcript and Presenter's Notes

Title: Insulin Delivery Devices Market share forecast to witness considerable growth from 2017 to 2024

Insulin Delivery Devices Market size is expected
to witness a considerable growth over the
forecast period- 2017-2024. Global Market
Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
Low Power Wide Area Network
Application of Insulin Delivery Devices Market
  • Homecare segment will continue to account for
    maximum market share during the forecast period.
    The significant factors resulting in substantial
    growth are growing adoption of insulin delivery
    devices and increasing awareness of diabetes
  • Home usage of insulin devices saves additional
    visiting costs, clinic, or hospital fee, and
    waiting time.
  • The developed devices including pens, pumps, and
    injectors, are small, highly portable, and give a
    comfort of using them anywhere and anytime.
    Therefore, better access to such delivery devices
    and their developed ease of usage has enabled
    insulin users opt for self-care diabetes
    management options.

Key Vendors of Insulin Delivery Devices Market
  • Companies operating in insulin delivery devices
    market include Novo Nordisk (Subsidiary of Novo
    A/S), Tandem Diabetes Care, Sanofi, Medtronic,
    Valeritas, Becton, Dickinson and Company, Eli
    Lilly, F. Hoffmann-La Roche and Ypsomed.
  • Owen Mumford, Animas, Insulet Corporation, Asante
    Solutions (Now Bigfoot Biomedical), Abbott
    Laboratories, Biocon Ltd., Antares Pharma,
    Bioject Medical Technologies, Injex - Equidyne
    Systems, Tonghua Dongbao Pharmaceutical, Shanghai
    Fosun Pharmaceutical.

Regional Analysis of Insulin Delivery Devices
  • U.S. insulin delivery devices market accounted
    for largest market share in 2016 owing to
    increasing awareness levels amongst the affected
  • India and China, are anticipated to witness
    significant growth during the forecast period due
    to the existence of a vast patient base suffering
    with diabetes and rising awareness of insulin
    delivery devices. In addition, large number of
    regional players are expanding their business by
    providing high-end products for diabetes care.


Browse Full Market Research Report On Insulin
Delivery Devices Market _at_ http//
Request for an in-depth table of contents for
this report _at_ http//
Stay In Touch Website Soci
al Media
Write a Comment
User Comments (0)